Home/ Supplements/ Vitamin K/ Vitamin K2 MK-7 (Menaquinone-7) 45 mcg

Vitamin K2 MK-7 (Menaquinone-7) 45 mcg

product on market Softgel Capsule Carlson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 MK-7 is supported by moderate evidence for its role in supporting bone health and regulating calcium deposition in the arteries. Research indicates that this specific form of vitamin K2 is more stable and remains in the bloodstream longer than MK-4. This ingredient is generally considered safe for consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 MK-7 (Menaquinone-7) 45 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
180
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mcg
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

Safflower Oil Soft Gel Shell Sunflower Oil Antioxidant Blend
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults: take one soft gel daily at mealtime.

Warnings & Precautions

Warning: Vitamin K can antagonize the effect of anticoagulants, including Warfarin. Do not take this product if you are taking Warfarin or are pregnant or breastfeeding without first consulting with your physician.

Formulation Notes

Bone support Cardiovascular function Calcium bioavailability

Gluten-free No artificial preservatives

Vitamin K as MK-7, derived from chickpeas, is important for the formation of strong, healthy bones and promotes arterial health.

Potency & quality guaranteed

An FDA regulated facility

Additional Information

Keep bottle tightly closed. Store away from heat and moisture.

Metadata

Product Details

UPC / SKU0 88395 10120 5
DSLD Entry Date2020-12-26
Product TypeVitamin
FormSoftgel Capsule
BrandCarlson
DSLD ID241633
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin K-2
GNC Preventive Nutrition · Softgel Capsule
100
Vitamin K-2
NewtonEverett · Softgel Capsule
100
Low-Dose Vitamin K2 45 mcg
Life Extension · Softgel Capsule
100
Natural Vitamin K-2 Bioactive Form
Vitamin World · Softgel Capsule
100
Vitamin K2 50 mcg
Vitacost · Softgel Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Carlson View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.